Caixin
Aug 31, 2021 08:00 AM

Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 26.3% in First Half of 2021

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 430.2 million yuan in the first half of 2021, up 26.3% year-on-year.

Meanwhile, the company posted 3.5 billion yuan in revenue, up 25.3% year-on-year.

At the end of the reporting period, it had 10.5 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 26.8%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin China Biz Roundup: Chinese Ambassador Warns U.S. Against Meddling in Taiwan
00:00
00:00/00:00